Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 06, 2013, 09:31 ET
Critical Alerts For Starbucks, Corning, Teva Pharmaceutical, Beazer Homes, and IMAX Released By InvestorsObserver
CHICAGO, May 6, 2013 InvestorsObserver issues critical PriceWatch Alerts for V, SBUX, GLW, TEVA, BZH, and IMAX. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at...
More news about: InvestorsObserver , Starbucks , Corning , Teva Pharmaceutical , Beazer Homes , IMAX
-
May 02, 2013, 16:00 ET
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided an overview of clinical development activities for its two product candidates, custirsen and OGX-427, and announced first quarter 2013 financial results. OGX-427 Program Update - In January 2013, the Company initiated the...
More news about: OncoGenex Pharmaceuticals, Inc. , Teva Pharmaceutical Industries Ltd.
-
Apr 11, 2013, 08:00 ET
OncoGenex Announces Plans for the Initiation of the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Spruce clinical trial, an investigator-sponsored, randomized, double-blind, placebo-controlled Phase 2 study evaluating OGX-427 in patients with previously untreated advanced non-squamous non-small...
More news about: OncoGenex Pharmaceuticals, Inc. , Teva Pharmaceutical Industries Ltd.
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |